Trial Profile
Long-Term Sorafenib Treatment in Patients with Advanced Hepatocellular Carcinoma in Indonesia: Multicenter experience
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Aug 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 28 Aug 2015 New trial record